The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection

Journal of Urology

Volumn 169, Issue 1, 2003, Pages 130-135

  Ung, Jean O ^a   San Francisco, Ignacio F ^a   Regan, Meredith M ^a   DeWolf, William C ^a   Olumi, Aria F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biopsy; Prostate specific antigen; Prostatic hyperplasia; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RISK FACTOR; SAMPLING; SERUM;

EID: 0037213845     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64052-9     Document Type: Article

References (20)

1. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 142: 71, 1989
2. Stricker, H. J., Ruddock, L. J., Wan, J. and Belville, W. D.: Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol, 71: 43, 1993
3. McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Pathol, 12: 897, 1988
4. Eskew, L. A., Bare, R. L. and McCullough, D. L.: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol, 157: 199, 1997
5. Uzzo, R. G., Wei, J. T., Waldbaum, R. S., Perlmutter, A. P., Byrne, J. C. and Vaughan, E. D., Jr.: The influence of prostate size on cancer detection. Urology, 46: 831, 1995
6. Karakiewicz, P. I., Bazinet, M., Aprikian, A. G., Trudel, C., Aronson, S., Nachabé, M. et al: Outcome of sextant biopsy according to gland volume. Urology, 49: 55, 1997
7. Letran, J. L., Meyer, G. E., Loberiza, F. R. and Brawer, M. K.: The effect of prostate volume on the yield of needle biopsy. J Urol, 160: 1718, 1998
8. Levine, M. A., Ittman, M., Melamed, J. and Lepor, H.: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol, 159: 471, 1998
9. Bostwick, D. G., Cooner, W. H., Denis, L., Jones, G. W., Scardino, P. T. and Murphy, G. P.: The association of benign prostatic hyperplasia and cancer of the prostate. Cancer, 70: 291, 1992
10. Vashi, A. R., Wojno, K. J., Gillespie, B. and Oesterling, J. E.: A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol, 159: 920, 1998
11. Lui, P. D., Terris, M. K., McNeal, J. E. and Stamey, T. A.: Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol, 153: 1000, 1995
12. Borboroglu, P. G., Sur, R. L., Roberts, J. L. and Amling, C. L.: Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol, 166: 866, 2001
13. Stewart, C. S., Leibovich, B. C., Weaver, A. L. and Lieber, M. M.: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol, 166: 86, 2001
14. Han, M., Partin, A. W., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol, 166: 416, 2001
15. Stamey, T. A.: Making the most out of six systematic sextant biopsies. Urology, 45: 2, 1995
16. Djavan, B., Ravery, V., Zlotta, A., Dobronski, P., Dobrovits, M., Fakhari, M. et al: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? J Urol, 166: 1679, 2001
17. Naughton, C. K., Miller, D. C., Mager, D. E., Ornstein, D. K. and Catalona, W. J.: A prospective randomized trial comparing 6 versus 12 prostate needle biopsy cores: Impact on cancer detection. J Urol, 164: 388, 2000
18. Kibel, A. S., Krithivas, K., Shamel, L. B., Kantoff, P. W. and DeWolf, W. C.: Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma. Urology, 48: 741, 1996
19. Mikolajczyk, S. D., Millar, L. S., Wang, T. J., Rittenhouse, H. G., Wolfert, R. L., Marks, L. S. et al: "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology, 55: 41, 2000
20. Mikolajczyk, S. D., Marker, K. M., Millar, L. S., Kumar, A., Saedi, M. S., Payne, J. K. et al: A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Cancer Res, 61: 6958, 2001